Cervical Cancer Diagnostics market: Increasing percentage of HPV infected people drives Cervical Cancer Diagnostics market

Cancer is a group of diseases involving abnormal growth of cells with the potential to spread to other parts of the body. There are various types of cancers affecting different parts of body. Cancer which develops in cervix is called cervical cancer. Two major types of cervical cancers diagnosed in women include adenocarcinoma and squamous cell carcinoma. Almost all types of cervical cancer are caused by human papiloma virus (HPV). Cervical cancer is the third most common cancer among women and the second most frequent cause of cancer-related death, accounting for almost 3,00,000 deaths annually. Diagnosis of cervical cancer is done by Pap Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC). Cervical cancer is a sexually transmitted disease that can be prevented by early detection and vaccination.

Request Sample Report: http://www.zionmarketresearch.com/sample/cervical-cancer-diagnostics-market

Cervical cancer diagnostics market is driven majorly by increasing percentage of HPV infected people across globe. HPV is an extremely common virus. According to the Centers for Disease Control and Prevention (CDC), six million people in the United States acquire HPV each year. At least 20 million already have it, and more than half of all sexually-active adults are expected to be infected during their lifetime. Furthermore, rising awareness, literacy rate, government initiatives, government funding and various screening methods are expected to increase the growth of the market over the years. Moreover, many lifestyle-related factors, such as having multiple sex partners, smoking, obesity, unsafe sex and inherited HPV positive patients, are estimated to drive the cervical diagnostics market in the near future. However prevention of HPV by vaccination is major restraining factor in the growth of cervical cancer diagnostics market. In addition to this, the uncertain returning policy serves to be a major challenge impacting the growth of cervical cancer diagnostics market.

The report covers forecast and analysis of the cervical cancer diagnostics market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million). To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the cervical cancer diagnostics market has also been included in the study. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period. The study encompasses a market attractiveness analysis, wherein application segments are benchmarked based on their market size, growth rate and general attractiveness.

Request TOC (Table of Contents) of this report: http://www.zionmarketresearch.com/toc/cervical-cancer-diagnostics-market

The report provides detailed segmentation of the cervical cancer diagnostics market based on application and region. The regional market segment held the largest market share in 2015.

Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global cervical cancer diagnostic market in 2015 on account of the rising incidence of HPV infection, rising number of women smokers, and growing aged population. North America was followed by Europe in 2015. The market is expected to witness the growth in the Asia-Pacific region in the coming years due to the rising HPV infection in population, government initiative and availability of advance health care infrastructure.

Browse report at: http://www.zionmarketresearch.com/report/cervical-cancer-diagnostics-market

Some of the key players contributing to the cervical cancer diagnostics market are Abbott Laboratories, Qiagen N.V., Hologic Inc., Roche Diagnostics, Quest Diagnostics, Becton, Dickinson and Company

This report segments the cervical cancer diagnostics market are follows:-

Cervical Cancer Diagnostics Market: Application Analysis

Pap Smear Tests
Colposcopy
HPV Testing

Do Inquiry before buying: http://www.zionmarketresearch.com/inquiry/cervical-cancer-diagnostics-market

Cervical Cancer Diagnostics Market: Regional Analysis

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

About Us:
Zion Market Research is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Zion Market Research is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading industry and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.

Contact Us:
Zion Market Research
4283, Express Lane,
Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: http://www.zionmarketresearch.com

This release was published on openPR.